Cancer treatment programmes at the Norwegian Radium Hospital
The Norwegian Radium Hospital (NRH) is constantly carrying out intensive research on new cancer treatment methods. The development of new treatments are initially taking place in laboratories by experimenting on isolated cells, tissue and in animal models. Drugs showing promising activities in the model systems are then tested out thoroughly in clinical studies on patients with cancer. A large number of the patients at the NRH are participating in various clinical studies.
The hospital activity is organized according to Treatment Programmes.
Each treatment program organize their own research activity.
Clinical research on new therapies and procedures in human beings is often time consuming and difficult to carry out at an ordinary hospital ward. The Norwegian Radium Hospital therefore established its Clinical Cancer Research Unit with its own doctors and specially trained nurses for early drug development (phase I and II studies).
When a new drug or a diagnostic method is established as safe and promising, they will undergo further testing in phase III studies were the new treatment is compared with standard treatment. Such studies are usually being carried out in collaboration with other centres nationally or internationally. All patients participating in clinical always receive detailed information about the nature of the study, its purpose, possible toxicities, potential gain for the patient and the right to withdraw from a study at any time and without giving a reason.
The Clinical Research Office is supporting the doctors at the NRH in preparing and implementing the clinical studies together with analysing and publishing the results.
The main task of the Division of Long Term Studies is to carry out follow-up examination and to give advice to groups of cancer patients who are expected to have an especially high risk of long term problems caused by their cancer disease, its diagnosis or treatment.
Go back
Print this page
E-mail this pageLandscape of cancer genes and mutational processes in breast cancer
May 21, 2012
